References
1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka
R, Roehr CC, Saugstad OD, Simeoni U, et al. European Consensus
Guidelines on the Management of Respiratory Distress Syndrome - 2019
Update. Neonatology. 2019;115(4):432-450.
2. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use
of surfactant in preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2012(3):Cd000510.
3. Zhang L, Cao HY, Zhao S, Yuan LJ, Han D, Jiang H, Wu S, Wu HM. Effect
of exogenous pulmonary surfactants on mortality rate in neonatal
respiratory distress syndrome: A network meta-analysis of randomized
controlled trials. Pulm Pharmacol Ther. 2015;34:46-54.
4. Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R.
Evolution of surfactant therapy for respiratory distress syndrome: past,
present, and future. Pediatr Res. 2017;81(1-2):240-248.
5. Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent
bronchopulmonary dysplasia: a meta-analysis. Pediatrics.2013;132(5):e1351-1360.
6. Carrasco Loza R, Villamizar Rodriguez G, Medel Fernandez N.
Ventilator-Induced Lung Injury (VILI) in Acute Respiratory Distress
Syndrome (ARDS): Volutrauma and Molecular Effects. Open Respir Med
J. 2015;9:112-119.
7. Leone F, Trevisanuto D, Cavallin F, Parotto M, Zanardo V. Efficacy of
INSURE during nasal CPAP in preterm infants with respiratory distress
syndrome. Minerva Pediatr. 2013;65(2):187-192.
8. Najafian B, Fakhraie SH, Afjeh SA, Kazemian M, Shohrati M, Saburi A.
Early surfactant therapy with nasal continuous positive airway pressure
or continued mechanical ventilation in very low birth weight neonates
with respiratory distress syndrome. Iran Red Crescent Med J.2014;16(4):e12206.
9. Gomes Cordeiro AM, Fernandes JC, Troster EJ. Possible risk factors
associated with moderate or severe airway injuries in children who
underwent endotracheal intubation. Pediatr Crit Care Med.2004;5(4):364-368.
10. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less
invasive surfactant administration-a survey. Eur J Pediatr.2017;176(2):147-154.
11. Wyckoff M, Aziz K, Escobedo M, et al. Part 13: Neonatal
Resuscitation: 2015 American Heart Association Guidelines Update for
Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.Circulation. 2015;132:S543-560.
12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis
JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement
for reporting systematic reviews and meta-analyses of studies that
evaluate health care interventions: explanation and elaboration.PLoS med. 2009;6(7):e1000100.
13. Higgins JP, Green S, editors. Cochrane handbook for systematic
reviews of interventions version 5.1.0.. The Cochrane
Collaboration. 2011. p 33–49. Available from:
www.handbook.cochrane.org.
14. Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J,
Avenarius S, von der Wense A, Vochem M, et al. Avoidance of mechanical
ventilation by surfactant treatment of spontaneously breathing preterm
infants (AMV): an open-label, randomised, controlled trial.Lancet. 2011;378(9803):1627-1634.
15. Heidarzadeh M, Mirnia K, Hoseini MB, Sadeghnia A, Akrami F, Balila
M, Ghojazadeh M, Shafai F. Surfactant Administration via Thin Catheter
during Spontaneous Breathing: Randomized Controlled Trial in Alzahra
hospital. Iran J Neonatol . 2013;4(2):5-9.
16. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant
administration via thin catheter during spontaneous breathing:
randomized controlled trial. Pediatrics. 2013;131(2):e502-509.
17. Mirnia K, Heidarzadeh M, Hosseini MB. Comparison Outcome of
Surfactant Administration Via Tracheal Catheterization During
Spontaneous Breathing with Insure. Med J Islamic World Acad Sci.2013;21(4):143-148.
18. Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive
surfactant administration in very preterm infants in a Chinese tertiary
center. BMC Pediatr. 2015;15:21.
19. Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, Teig N, Hoehn
T, Böhm W, Welzing L, et al. Nonintubated Surfactant Application vs
Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical
Trial. JAMA Pediatr. 2015;169(8):723-730.
20. Mohammadizadeh M, Ardestani AG, Sadeghnia AR. Early administration
of surfactant via a thin intratracheal catheter in preterm infants with
respiratory distress syndrome: Feasibility and outcome. J Res
Pharm Pract. 2015;4(1):31-36.
21. Mosayebi Z, Kadivar M, Taheri-Derakhsh N, Nariman S, Mahdi Marashi
S, Farsi Z. A Randomized Trial Comparing Surfactant Administration Using
InSurE Technique and the Minimally Invasive Surfactant Therapy in
Preterm Infants (28 to 34 Weeks of Gestation) with Respiratory Distress
Syndrome. J Compr Ped. 2017;In Press(In Press): :e60724.
22. Halim A, Shirazi H, Riaz S, Gul S, Ali W. Less Invasive Surfactant
Administration in Preterm Infants with Respiratory Distress Syndrome.J Coll Physicians Surg Pak. 2019;29(3):226-330.
23. Jena SR, Bains HS, Pandita A, et al. Surfactant therapy in premature
babies: SurE or InSurE. Pediatr Pulmonol. 2019;54(11):1747-1752.
24. Gupta BK, Saha AK, Mukherjee S, Saha B. Minimally invasive
surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks
with respiratory distress syndrome on non-invasive positive pressure
ventilation-a randomized controlled trial. Eur J Pediatr.2020;179(8):1287-1293.
25. Han T, Liu H, Zhang H, Guo M, Zhang X, Duan Y, Sun F, Liu X, Zhang
X, Zhang M, et al. Minimally Invasive Surfactant Administration for the
Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter
Randomized Study in China. Front Pediatr. 2020;8:182.
26. Yang G, Hei M, Xue Z, Zhao Y, Zhang X, Wang C. Effects of less
invasive surfactant administration (LISA) via a gastric tube on the
treatment of respiratory distress syndrome in premature infants aged 32
to 36 weeks. Medicine (Baltimore). 2020;99(9):e19216.
27. Lin HJ, Du LZ, Ma XL, Shi LP, Pan JH, Tong XM, Li QP, Zhou JG, Yi B,
Liu L, et al. Mortality and Morbidity of Extremely Low Birth Weight
Infants in the Mainland of China: A Multi-center Study. Chin Med J
(Engl). 2015;128(20):2743-2750.
28. Wu F, Liu G, Feng Z, Tan X, Yang C, Ye X, Dai Y, Liang W, Ye X, Mo
J, et al. Short-term outcomes of extremely preterm infants at discharge:
a multicenter study from Guangdong province during 2008-2017. BMC
Pediatr. 2019;19(1):405.
29. Clyman RI. The role of patent ductus arteriosus and its treatments
in the development of bronchopulmonary dysplasia. Semin
Perinatol. 2013;37(2):102-107.
30. Sato K, Nakashima T. Histopathologic changes in laryngeal mucosa of
extremely low-birth weight infants after endotracheal intubation.Ann Otol Rhinol Laryngol. 2006;115(11):816-823.
31. Sharma GK, Ahuja GS, Wiedmann M, Osann KE, Su E, Heidari AE, Jing
JC, Qu Y, Lazarow F, Wang A, et al. Long-Range Optical Coherence
Tomography of the Neonatal Upper Airway for Early Diagnosis of
Intubation-related Subglottic Injury. Am J Respir Crit Care Med.2015;192(12):1504-1513.
32. Abdel-Latif M, Osborn D. Nebulised surfactant in preterm infants
with or at risk of respiratory distress syndrome. Database Syst
Rev. 2012;10:CD008310.
33. Barbosa RF, Simoes ESAC, Silva YP. A randomized controlled trial of
the laryngeal mask airway for surfactant administration in neonates.J Pediatr (Rio J). 2017;93(4):343-350.
34. Roberts KD, Brown R, Lampland AL, et al. Laryngeal Mask Airway for
Surfactant Administration in Neonates: A Randomized, Controlled Trial.J Pediatr. 2018;193:40-46 e41.
35. Ten centre trial of artificial surfactant (artificial lung expanding
compound) in very premature babies. Ten Centre Study Group. Br Med
J (Clin Res Ed). 1987;294(6578):991-996.
36. Barkhuff W, Soll R. Novel Surfactant Administration Techniques: Will
They Change Outcome? Neonatology. 2019;115(4):411-422.
37. Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less
invasive surfactant administration (LISA) in the United States with
review of the literature. J Perinatol. 2019;39(3):426-432.
38. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner
O, Vilstrup CT. Manual ventilation with a few large breaths at birth
compromises the therapeutic effect of subsequent surfactant replacement
in immature lambs. Pediatr Res. 1997;42(3):348-355.
39. Herting E, Hartel C, Gopel W. Less invasive surfactant
administration (LISA): chances and limitations. Arch Dis Child
Fetal Neonatal Ed. 2019;104(6):F655-F659.
40. More K, Sakhuja P, Shah PS. Minimally invasive surfactant
administration in preterm infants: a meta-narrative review. JAMA
Pediatr. 2014;168(10):901-908.
41. Isayama T, Iwami H, McDonald S, Beyene J. Association of Noninvasive
Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia
Among Preterm Infants: A Systematic Review and Meta-analysis.JAMA. 2016;316(6):611-624.
42. Langhammer K, Roth B, Kribs A, Göpel W, Kuntz L, Miedaner F.
Treatment and outcome data of very low birth weight infants treated with
less invasive surfactant administration in comparison to intubation and
mechanical ventilation in the clinical setting of a cross-sectional
observational multicenter study. Eur J Pediatr.2018;177(8):1207-1217.
43. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive
surfactant administration versus intubation for surfactant delivery in
preterm infants with respiratory distress syndrome: a systematic review
and meta-analysis. Arch Dis Child Fetal Neonatal Ed.2017;102(1):F17-F23.